REGN vs. BIL

Last updated Jun 4, 2026

REGN (Regeneron Pharmaceuticals, Inc.) is a stock, while BIL (SPDR Bloomberg 1-3 Month T-Bill ETF) is Government Bonds fund tracking the Bloomberg 1-3 Month U.S. Treasury Bill Index. Over the past 10 years, REGN returned 4.53%/yr vs 2.18%/yr for BIL. At a correlation of -0.05, they often move in opposite directions.

Performance

REGN vs. BIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regeneron Pharmaceuticals, Inc. (REGN) and SPDR Bloomberg 1-3 Month T-Bill ETF (BIL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, REGN achieves a -19.60% return, which is significantly lower than BIL's 1.49% return. Over the past 10 years, REGN has outperformed BIL with an annualized return of 4.53%, while BIL has yielded a comparatively lower 2.18% annualized return.

REGN

• 1D: 2.66%
• 1M: -12.60%
• YTD: -19.60%
• 6M: -14.24%
• 1Y: 27.57%
• 3Y*: -5.52%
• 5Y*: 4.04%
• 10Y*: 4.53%

BIL

• 1D: 0.02%
• 1M: 0.28%
• YTD: 1.49%
• 6M: 1.77%
• 1Y: 3.87%
• 3Y*: 4.64%
• 5Y*: 3.41%
• 10Y*: 2.18%

*Multi-year figures are annualized to reflect compound growth (CAGR)

REGN vs. BIL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
REGN Regeneron Pharmaceuticals, Inc.	-19.60%	8.96%	-18.90%	21.73%	14.25%	30.72%	28.66%	0.53%	-0.65%	2.42%
BIL SPDR Bloomberg 1-3 Month T-Bill ETF	1.49%	4.15%	5.19%	4.94%	1.40%	-0.10%	0.40%	2.03%	1.74%	0.69%

Correlation

The correlation between REGN and BIL is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	-0.04
Correlation (5Y) Calculated over the trailing 5-year period	-0.06
Correlation (10Y) Calculated over the trailing 10-year period	-0.05
Correlation (All Time) Calculated using the full available price history since May 31, 2007	-0.05

Return for Risk

REGN vs. BIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REGN

REGN Risk / Return Rank: 64
REGN Sharpe Ratio Rank: 67
REGN Sortino Ratio Rank: 62
REGN Omega Ratio Rank: 60
REGN Calmar Ratio Rank: 62
REGN Martin Ratio Rank: 70

BIL

BIL Risk / Return Rank: 100
BIL Sharpe Ratio Rank: 100
BIL Sortino Ratio Rank: 100
BIL Omega Ratio Rank: 100
BIL Calmar Ratio Rank: 100
BIL Martin Ratio Rank: 100

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REGN vs. BIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regeneron Pharmaceuticals, Inc. (REGN) and SPDR Bloomberg 1-3 Month T-Bill ETF (BIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	REGN	BIL	Difference
Sharpe ratio: Return per unit of total volatility	0.84	19.71	-18.87
Sortino ratio: Return per unit of downside risk	1.38	174.16	-172.78
Omega ratio: Gain probability vs. loss probability	1.17	87.91	-86.74
Calmar ratio: Return relative to maximum drawdown	1.07	355.35	-354.28
Martin ratio: Return relative to average drawdown	3.78	2,817.77	-2,813.99
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

REGN vs. BIL - Sharpe Ratio Comparison

The current REGN Sharpe Ratio is 0.84, which is lower than the BIL Sharpe Ratio of 19.71. The chart below compares the historical Sharpe Ratios of REGN and BIL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	REGN	BIL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.84	19.71	-18.87
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.13	13.16	-13.03
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.14	8.52	-8.38
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	2.78	-2.62

Drawdowns

REGN vs. BIL - Drawdown Comparison

The maximum REGN drawdown since its inception was -91.81%, which is greater than BIL's maximum drawdown of -0.78%. Use the drawdown chart below to compare losses from any high point for REGN and BIL.

Drawdown Indicators

	REGN	BIL	Difference
Max Drawdown Largest peak-to-trough decline	-91.81%	-0.78%	-91.03%
Max Drawdown (1Y) Largest decline over 1 year	-25.85%	-0.01%	-25.84%
Max Drawdown (3Y) Largest decline over 3 years	-59.69%	-0.01%	-59.68%
Max Drawdown (5Y) Largest decline over 5 years	-59.69%	-0.10%	-59.59%
Max Drawdown (10Y) Largest decline over 10 years	-59.69%	-0.21%	-59.48%
Current Drawdown Current decline from peak	-48.07%	0.00%	-48.07%
Average Drawdown Average peak-to-trough decline	-42.38%	-0.26%	-42.12%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.31%	0.00%	+7.31%

Volatility

REGN vs. BIL - Volatility Comparison

Regeneron Pharmaceuticals, Inc. (REGN) has a higher volatility of 12.35% compared to SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) at 0.05%. This indicates that REGN's price experiences larger fluctuations and is considered to be riskier than BIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	REGN	BIL	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.35%	0.05%	+12.30%
Volatility (6M) Calculated over the trailing 6-month period	22.35%	0.13%	+22.22%
Volatility (1Y) Calculated over the trailing 1-year period	32.82%	0.20%	+32.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.77%	0.26%	+30.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	32.16%	0.26%	+31.90%

Dividends

REGN vs. BIL - Dividend Comparison

REGN's dividend yield for the trailing twelve months is around 0.59%, less than BIL's 3.86% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
BIL SPDR Bloomberg 1-3 Month T-Bill ETF	3.86%	4.13%	5.03%	4.92%	1.35%	0.00%	0.30%	2.05%	1.66%	0.68%	0.07%
REGN Regeneron Pharmaceuticals, Inc.	0.59%	0.46%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both REGN and BIL in my portfolio?

REGN and BIL have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, REGN or BIL?

REGN has higher volatility (12.35%) compared to BIL (0.05%). In terms of maximum drawdown, REGN dropped -91.81% vs BIL's -0.78%.

Which has better risk-adjusted returns?

BIL currently has the higher Sharpe Ratio (19.71 vs 0.84), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.